Here, we report the identification of the ubiquitin-like gene UBD as a downstream element of FOXP3 in human activated regulatory CD4 þ CD25 hi T cells (T reg ). Retroviral transduction of UBD in human allo-reactive effector 
Regulatory CD4 þ CD25 þ T (T reg ) cells have emerged as a unique population of suppressor T cells that are important for the maintenance of peripheral tolerance. 1, 2 In humans, T reg cells are characterized by high levels of CD25 expression (CD25 hi ) and represent 1-3% of all CD4 þ T cells in peripheral blood. 3 Typically, such T reg cells are anergic upon stimulation via their T-cell receptor and exhibit suppressive activity towards effector T-cell function. 2 The clinical relevance of CD4 þ CD25 hi T reg cells has recently been illustrated in different human disease settings, that is, altered numbers and impairment of suppressor activity of T reg cells has been demonstrated in patients with Hodgkin's lymphomas, autoimmune polyglandular syndrome type II, multiple sclerosis, myasthenia gravis, diabetes, psoriasis, patients with graft-versus-host-disease, and infectious diseases such as malaria and HIV. [4] [5] [6] [7] [8] [9] [10] [11] [12] Development and function of T reg cells critically depend on the forkhead transcription factor FOXP3 that specifies the regulatory T cell lineage. 13 As a result, humans and mice deficient in FOXP3 lack CD4 þ CD25 þ T reg cells and suffer from multiorgan autoimmune disease. 2 T reg cells normally develop in the thymus. However, they also may arise in a FOXP3-dependent manner from peripheral CD4 þ CD25 À T cells. 14, 15 The antigen-specificity of T reg cells is currently a matter of debate, although self-antigens most likely represent the dominating specificity. [16] [17] [18] [19] Mechanisms of immunosuppression by T reg cells comprise cell-contact dependent suppression, mainly observed in vitro, and cytokine-mediated suppression of effector T cells, mainly observed in vivo. 20 Cytokines most commonly found are IL10 and TGF-b, which also modulate T reg cell function in vivo and T reg cell development from nonregulatory CD4 þ CD25 À T cells in vitro. 14, 17, 21, 22 However, IL10 and TGF-b are not essential for the development and function of T reg cells. 23, 24 CTLA4 also functions as an important mediator and modulator of T reg cell activity. 20 This member of the CD28-family is constitutively expressed at high levels in CD4 þ CD25 þ T reg cells in mouse and man. In the human system, CTLA4
þ T reg cells display a stronger suppressive activity in vitro than CTLA4 À T reg cells. 25 However, CTLA4 is not essential for the development and function of T reg cells, since its loss could be compensated by increased secretion of IL10 and TGF-b by CTLA4
À CD4 þ CD25 þ T reg cells. 26 The conversion of murine naïve nonregulatory CD4 þ CD25 À T cells into T reg cells by retroviral overexpression of FOXP3 underlines the master control function of this transcription factor. 27, 28 Consequently, the use of FOXP3 as a tool for potential clinical T reg cell therapy has been demonstrated recently in mice. Retroviral transduction of FOXP3 in polyclonal or antigen-specific naïve CD4 þ CD25 À T cells generated T reg cells that suppressed the development of inflammatory bowl disease, autoimmune gastritis, diabetes or contact allergy, and induced transplant tolerance in vivo. 27, [29] [30] [31] Despite these encouraging results in mice, debate exists about the efficacy of FOXP3 to reprogram human naïve CD4 þ T cells towards a regulatory phenotype. [32] [33] [34] The most likely reason for this ambiguity arises from the fact that unlike murine naïve and effector CD4 þ T helper cells, human nonregulatory CD4 þ T cells do express FOXP3. 35 Thus, the fundamental role of FOXP3 is well established, but target genes involved in the control of the FOXP3-dependent regulatory phenotype still require defining. 36 However, precise knowledge of this, including considerations of the differences between FOXP3 in mice and men, 35 hi T reg cells were stimulated once with plate-bound anti-CD3 (TR66, 1 mg/ml), soluble anti-CD28 (CD28.2, 1 mg/ml, BD), and 50 U/ml recombinant human IL2 (Proleukin, provided by P Wagner, Chiron Corporation, Emeryville, CA, USA), and thereafter weekly with irradiated allogeneic EBV-transformed B cells (LG2-EBV, provided by T Boon, LICR, Brussels, Belgium). CD4 þ CD25 À T cells were used to establish long-term, allo-reactive effector T h cell lines against LG2-EBV cells. Culture medium was IMDM, with 10% FCS, 100 U/ml penicillin/streptomycin, and nonessential amino acids (PAA Laboratories, Linz, Austria). Human peripheral blood was obtained after informed consent according to the MHH guidelines.
Antibodies
For immunostaining PE-, FITC-, APC-, and CyChrom-conjugated Abs against CD4 (RPA-T4), CD25 (M-A251), CD28 (CD28.2), TCRab (T10B9.1A-31), CTLA4 (BNI3), LGALS3 (B2C10; all from BD, Bioscience, San Jose, CA, USA), and FOXP3 (PCH101, eBioscine Inc., San Diego, CA, USA) and the respective isotype controls were used. For FOXP3 staining, murine hybridoma T cell transduced with human FOXP3 or GFP were included as further control. Anti-CD3e (TR66, produced from hybridoma supernatants) and anti-CD28 (CD28.2, BD) were used for T-cell stimulation. were stimulated in coverslip-chambers (Nunc) precoated with 10 mg/ml anti-CD3 (TR66) using confocal microscopy (BIO-Rad, Hercules, CA, USA).
Analysing T-Cell Functions

Retroviral Transduction of Human Effector CD4
þ
T Cells
The cDNAs encoding human FOXP3, CTLA4, and UBD were amplified from cDNA of T reg cells using high fidelity PFU polymerase (Promega) and specific primers (FOXP3: . PCR products were cloned into pCR4.1 TOPO (Invitrogen, Carlsbad, CA, USA), sequenced, and inserted into a pMSCV-based retroviral vector encoding an enhanced GFP (GFP) under the control of an IRES sequence. 37 The amphotropic PT67 packaging cell line (provided by M Wirth, GBF) was transfected as described elsewhere. 37 Filtered (0.45 mm) virus-containing supernatant supplemented with 8 mg/ml sequabrene (Sigma) was applied to differentiated allo-reactive T h cells, established as described above, at day 2 after allogeneic stimulation by centrifugation at 5000 g for 60 min at room temperature. Cells were expanded thereafter with 50 U/ml IL2, and GFP expressing cells were sorted 1 to 2 weeks later using a FACS-Vantage (BD). Sorted cells were kept for up to 3 months using the restimulation procedure described above and were tested repeatedly for stable functional, phenotypic, and transcriptional changes.
Quantitative and Semiquantitative RT-PCR
Total RNA was isolated from CD4 þ T cells using RNAeasy (Qiagen, Hilden, Germany) or nucleospin RNA-II (Macherey Nagel, Dü ren, Germany). cDNA synthesis was performed using oligo-dT primers and Superscript II Reverse Transcriptase (Invitrogen). Quantitative Real-time PCR was performed on an ABI PRISM 7000 cycler (Applied Biosystems, Foster City, CA, USA) using the SYBR Green PCR kit (Stratagene, La Jolla, CA, USA), and primers specific for 
GeneChip Assays and Microarray Data Analysis
For the screening of similarly regulated genes in T reg versus T h cells compared to T h FOXP3 versus T h GFP 
Results
Characterization of Human CD4 þ CD25 hi Derived T reg Cells Figure 1b) . The suppressive activity of such T reg cells was overcome by the addition of more than 10 U/ml IL2 (Supplementary Figure 1b) and required cellcontact since it was blocked by a transwell membrane (Supplementary Figure 1c) . Phenotypical analysis revealed stable expression of high levels of CD25, CD28, and intracellular CTLA4 (data not shown) as well as FOXP3 mRNA independent of their activation status (Supplementary Figure 1d) . Thus, CD4
þ CD25 hi derived T reg cells sorted and expanded by our protocol maintained high level of sustained FOXP3 expression associated with phenotypic and functional stability. Ca 2 þ metabolism is essential for the regulation of anergy 38 and has recently been shown to be impaired in murine CD4 þ CD25 þ T reg cells analyzed ex vivo. 39 In contrast to the latter report, our human T reg cells showed signs of sustained Ca 2 þ -flux upon anti-CD3 stimulation. This was reflected in the prolonged time required to reach the lower plateau level, following the initial Ca 2 þ -rise, and was also higher than that found for T h cells ( Supplementary  Figure 2a) . Consistent results were obtained at the single cell level (Supplementary Figure 2b and c) .
Differences between T reg and T h cells were also observed in the extent of anti-CD3 induced TCR downmodulation, which was strongly impaired in T reg cells (Supplementary Figure 2d) . This finding is in line with the observation that the extent of TCR downmodulation following ligand binding correlates with the induction of effector function. 40 In summary, the T reg cell lines established by our protocol showed all the phenotypic and functional characteristic of bona fide regulatory CD4 þ CD25 hi T reg cells and thus can be used to establish the mechanisms of FOXP3-dependent gene regulation.
FOXP3 Overexpression in Human Effector T h Cells Induces a Partial Regulatory Phenotype
To identify relevant FOXP3-dependent genes associated with the regulatory phenotype, we used retroviral overexpression of FOXP3 in human alloantigen specific effector T h cells (T h FOXP3). Successfully transduced T h cells were sorted for GFP þ, reintroduced into culture, and tested repeatedly over a period of up to 3 months. FOXP3-transduced T h cells were impaired in their proliferative response upon antigen-specific stimulation using allogeneic EBV-transformed B cells or stimulation with anti-CD3, reversed by the addition of IL2 (Figure 1a ). In addition, T h FOXP3 cells acquired suppressor activity towards effector T h cells stimulated by allogeneic EBV-transformed B cells, but this was not observed in control T h cells transduced with GFP (T h GFP) or CTLA4 (T h CTLA4) (Figure 1b ). Thus, FOXP3 was able to specifically reprogram differentiation of helper T cells towards a regulatory phenotype. However, compared to naturally occurring T reg cells, this regulatory phenotype was less pronounced (Figure 1a and b) .
In contrast, overexpression of CTLA4 did not induce a regulatory phenotype in T h cells, although the levels of intracellular CTLA4 expression were similar to T reg cells (Figure 1c) . A possible contribution of CTLA4 to the FOXP3-dependent transcriptional control is therefore unresolved at this point.
We then analyzed the anti-CD3 induced TCR downmodulation. Similar to T reg cells, T h FOXP3 cells showed an impaired downmodulation of TCR expression that was not observed in T h GFP or T h CTLA4 cells (Figure 1d ). Interestingly, this impairment of TCR downmodulation appears to be a general effect of FOXP3 as it was even observed in murine hybridoma T cells transduced with FOXP3. However, such hybridoma T cells did not acquire an anergic phenotype, although they showed upregulation of CD25 and impaired NFAT function (data not shown). Therefore, a high level of sustained FOXP3 mRNA ( Figure 1e ) and protein expression in T h FOXP3 cells (Figure 1f) induced most of the characteristics of the FOXP3-dependent regulatory phenotype.
It should be noted that in long-term cultures, T h FOXP3 cells were able to escape the FOXP3-dependent control. Most likely, the appearance of T cells with lower expression levels of FOXP3 was responsible for this phenomenon, since such T cells also showed reduced expression of the co-transduced IRES-driven GFP. As a result, re-sorting of long-term cultured T h FOXP3 cells for high expression of GFP re-established their regulatory phenotype (data not shown).
In addition, T h FOXP3 cells did not reach the same high levels of CD25 expression (Figure 2a ) while CD28 was present at similar levels in both types of cells (data not shown). We, therefore, analyzed the functional properties of T h FOXP3 cells expressing different levels of CD25 (Figure 2b ). CD25 hi T h FOXP3 cells showed a more pronounced regula- (Figure 2c and d) . Again, CD25 expression decreased in long-term culture despite the presence of FOXP3 (data not shown). This suggests that the T h cell specific regulation of CD25 expression is only transiently overcome by FOXP3 overexpression in differentiated effector T h cells.
Gene Expression Profiles of T reg Cells and T h FOXP3 Cells
The data presented above provide a biological framework for the identification of genes associated with the FOXP3-dependent regulatory phenotype. Using GeneChip analysis, we screened for genes similarly regulated in both T reg and T h FOXP3 cells compared to T h and T h GFP cells. According to our stringent selection criteria, 39 genes were defined that were similarly regulated in both regulatory T-cell populations. As expected, known markers of T reg cells were identified, that is CD25, CTLA4, TNFRSF1B, and CCR7. In addition, we found genes that were not previously associated with FOXP3-dependent transcriptional control, for instance the ubiquitin-like gene diubiquitin (UBD) and the b-galactoside binding lectin LGALS3 (Table 1) . Proteins involved in ubiquitinylation play an important role in the regulation of T-cell anergy. 41 Hence, we analyzed the potential contribution of UBD to the FOXP3-dependent transcriptional control in more detail.
UBD is Involved in the Regulation of CD4
þ T-Cell Anergy UBD is expressed at high levels in CD4 þ CD25 hi derived T reg cells and consistently upregulated in FOXP3-overexpressing T h cells compared to T h GFP and T h CTLA4 cells (Figure 3a) . Unlike FOXP3, which is expressed at sustained high levels, UBD expression is transiently downregulated following T-cell activation using anti-CD3/-CD28 antibodies and IL2 (Figure 3a) . Overexpression of UBD in T h cells (T h UBD) via retroviral transduction induced upregulation of CD25 without affecting CD28 expression ( Figure  3b) . In long-term T h UBD cell lines, significant impairment of proliferation upon TCR stimulation was observed, which was reversed by the addition of IL2 (Figure 3c ). Similar to FOXP3, overexpression of UBD in effector T h cells did not suppress IL10 and IFNg secretion (Figure 3d) . Importantly, FOXP3 expression was not upregulated in T h UBD cells (Figure 4a and b) suggesting that UBD is a key player in the regulation of anergy in T reg cells downstream of FOXP3.
Like T h FOXP3 cells, mRNA of IL5 and IL4 was significantly downregulated in T h UBD cells ( Figure  4a ). Whereas GATA3, regulating T h 2 specific IL5 and IL4 cytokine expression, was unaltered (Figure 4a) , 42 LGALS3, which has been described to downregulate expression of IL4 and IL5 mRNA, 43 was only slightly induced (Figure 4a and c) . Thus, UBD appears to be responsible for the IL4/IL5 downregulation as a downstream effector of FOXP3.
We then analyzed the influence of UBD overexpression on TCR downmodulation and Ca 2 þ -mobilization. Interestingly, UBD did not impair the anti-CD3 induced TCR downmodulation observed with T reg cells and T h FOXP3 cells (data not shown). However, Ca 2 þ -mobilization was influenced ( Figure  4d ). Whereas FOXP3 overexpression induced a slightly elevated steady-state phase of Ca 2 þ -flux compared to T h GFP cells, this state was lower in T h cells overexpressing UBD (Figure 4d ). 
UBD and LGALS3 represent FOXP3-dependent genes F Ocklenburg et al
Since ionomycin is known to induce ubiuqitinligases associated with anergy, 38 we investigated the effect of ionomycin treatment on UBD expression in T h cells. As predicted, ionomycin induced upregulation of UBD mRNA (Figure 4e ), but at the same time, FOXP3 mRNA expression was downregulated despite overexpression of UBD (Figure 4e ). This suggests that the ionomycin-induced anergic state is independent of FOXP3 and confirms that UBD does not induce the expression of FOXP3. Interestingly, similar to overexpression of FOXP3 in T h cells (Figure 4f) , overexpression of UBD together with ionomycin-induced sustained Ca 2 þ -flux upregulated IL1R2 mRNA expression ( Figure 4e ). As FOXP3 overexpression leads to the upregulation of UBD and in parallel increases the levels of TCRstimulated Ca 2 þ -flux, both UBD together with an elevated Ca 2 þ -flux seem to cooperatively regulate the expression of IL1R2. On the other hand, ionomycin did not improve the suppressive activity of T h cells overexpressing UBD (data not shown), indicating that high levels of FOXP3 are required to obtain a suppressive phenotype.
High LGALS3 Protein Expression Specifies a FOXP3-Dependent Signature of Human T reg Cells
We extended our GeneChip expression analysis of T h FOXP3 and T reg cells to T h UBD cells. Regulated Since upregulation of LGALS3 mRNA was common to T reg cells and T h cells overexpressing FOXP3 and UBD, respectively, we analyzed LGALS3 protein expression in these cells. Interestingly, high sustained levels of LGALS3 protein expression were detected only in T reg cells (Figure 5b) . Whereas significant induction of LGALS3 protein was also observed in T h FOXP3 cells, UBD overexpression in T h cells only minimally affected LGALS3 protein expression (Figure 5b ). Contrary to mice, 44 LGALS3 protein was not significantly induced in human nonregulatory effector T cells following stimulation with allogeneic EBV-transformed B cells and IL2, although upregulation of intranuclear FOXP3, cell surface CD25, and intracellular CTLA4 protein expression was observed in such cells (Figure 5c ). As LGALS3 protein expression is restricted at low levels to nonactivated human peripheral blood CD4 þ CD25 þ T cells (Figure 5e ), high level of LGALS3 protein expression represents a T reg -specific FOXP3 signature of antigen-stimulated human CD4
þ CD25 hi -derived T reg cells.
LGALS3 has been described to induce T-cell apoptosis in human T cells via a lactose-dependent binding to CD7 and CD29. 45 Therefore, we analyzed the suppressor function of T reg cells in the presence or absence of 50 mM lactose, which potently impairs the apoptotic function of LGALS3. 45 But no impairment of T reg cell suppressor function was observed suggesting that LGALS3 is not directly involved in T reg cell suppression (Figure 5f ).
Discussion
In the present study we compared the genetic program of human CD4 þ CD25 hi derived T reg cells with that of allo-reactive effector T h cells reprogrammed towards a partial regulatory phenotype by retroviral transduction of FOXP3. The reason for such an approach was to unmask FOXP3-dependent genes by mimicking sustained high levels of FOXP3 expression in T h cells and to reduce the size of differentially expressed genes to the most significant set. Critical FOXP3-dependent target genes were identified.
One of the genes consistently upregulated was the ubiquitin-like gene diubiquitin (UBD, also known as FAT10). UBD has been initially cloned as a gene exclusively expressed in dendritic cells and mature B cells. 46 It was reported to be involved in protein degradation, apoptosis, and control of spindle assembly. 47, 48 Moreover, UBD expression can be induced by IFNg, whereas another IFNg inducible gene, NEDD8 ultimate buster-1L (NUB1L), has been reported to accelerate the degradation of UBD. 49 A potential function of UBD in the physiology of human T reg cells has not been addressed so far. This is most likely due to the fact that UBD expression is Since FOXP3 is a transcriptional repressor, 36, 50 upregulation of UBD expression should not be directly induced by FOXP3. Rather, UBD transcription should be indirectly regulated, for example, by downregulating transcriptional repressors of UBD. This is supported by preliminary experiments in Figure 4 UBD expression impairs T-cell proliferation independent of FOXP3. (a) Effector T h cells transduced as described in Figure 3b were tested by semiquantitative RT-PCR as described in Figure 3a Supplementary Figure 2a. (e) T h GFP and T h UBD cells were tested for upregulation of IL1R2, FOXP3, and UBD mRNA. Ionomycin (Io) or vehicle (DMSO) was added. Determination was carried out after 24 h by semiquantitative RT-PCR as described in Figure 3a. (f) IL1R2 specific mRNA was determined in T h FOXP3, T h UBD, and T h GFP cells of Figure 3b by semiquantitative RT-PCR. Note that no signal is obtained in T h UBD as in T h GFP cells. The slight discrepancy between e and f in this respect is most likely due to differences between the individual donors of T h cells. which a 1.5 kb genomic DNA fragment preceding the transcriptional start of UBD was tested in a reporter system. No reporter activity was induced by FOXP3 (unpublished data).
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LGALS3 How UBD mediates transcriptional control is questionable. It is known that E3-ubiquitin ligases such as Itch, Cbl-b, and Grail play an essential role in the induction of T-cell anergy. Their mode of action is to target key TCR signaling molecules for degradation that are localized in the cytoplasm. 38, 51 UBD has similarly been reported to target proteins for degradation but not in the context of TCR signal transduction. However, UBD has also been found to be localized in the nucleus. 52 Therefore, its main effect might be a transcriptional modulation, as the activity of many signal transduction pathways and transcription factors are regulated by ubiquitin-mediated proteolytic and nonproteolytic mechanisms. 53, 54 Whatever the mechanisms, our extended transcriptome analysis of T reg cells compared to T h FOXP3 and T h UBD cells suggested that LGALS3 might play a central role for some of the overlapping functional and phenotypic changes observed in these cells.
LGALS3 represents a unique member of the family of b-galactoside-binding proteins. It is composed of a small N-terminal domain, which controls its subcellular targeting, a repetitive collagen-like region that serves as substrate for matrix metalloproteinases, and a C-terminal carbohydrate-recognition domain. 55 Expression of LGALS3 has been observed in different tissues and cells types. It displays pleiotropic biological functions depending on subcellular localization. Extracellular LGALS3 binds to cells through glycosylated receptors, thereby triggering or modulating cellular responses such as mediator release, apoptosis, cell adhesion, and migration. 45, 56 Intracellular LGALS3 has been reported to inhibit apoptosis 57 and the cell cycle. 58 Interestingly, upregulation of LGALS3 has been observed during neoplastic transformation in several human malignancies. 59 Moreover, LGALS3 has been found in the nucleus, where it is reported to be involved in pre-mRNA splicing, 60 and the regulation of gene expression (eg cyclinD and Muc2) through the activation of specific transcription factors, including AP1, NFAT, SP1, and CREB. 61, 62 Serine phosphorylation and dephosporylation at position 6 of LGALS3 by casein kinase 1 and protein phosphatase 1, respectively, controls the carbohydrate binding capability, nuclear localization, transcriptional modulation, and antiapoptotic function of LGALS3. 58, 63, 64 Diversified functions of LGALS3 have also been reported for cells of the immune system. LGALS3 has been detected in monocytes and macrophages, dendritic cells, mast cells, murine T cells, and granulocytes. 65 Several important processes and functions are modulated by LGALS3 in these cells including thymocyte migration, 66 innate immunity against infections, 67 inflammation, 68 and T-cell apoptosis. 45, 69 Owing to the nondifferential expression of LGALS3 in activated murine CD8 þ and CD4 þ T cells, 44 it was unexpected that LGALS3 might act as a T reg -specific marker. However, only low levels of LGALS3 protein were detectable in human peripheral blood CD4 þ CD25 þ T cells, but sustained high levels were induced in naturally derived human CD4 þ CD25 hi T reg cells following antigenic stimulation in vitro. Similarly, upregulation of LGALS3 protein expression was observed in FOXP3-transduced effector T h cells reprogrammed towards a partial regulatory phenotype. This indicates that LGALS3 protein expression in fact represents a FOXP3-signature of the regulatory program.
The potential contribution of LGALS3 to the function of activated T reg cells is speculative. The anti-apoptotic activity of LGALS3 might protect T reg cells from apoptotic signals through CD95, 70 which is expressed at high levels on T reg cells. Alternatively, the activation and modulation of specific transcription factors, like AP1, NFAT, SP1, and CREB, 61, 62 might contribute to the FOXP3-dependent transcriptional control. However, more direct effects of LGALS3 on T reg cell functions have to be considered. In murine T cells, a direct association of LGALS3 with the TCR complex, restricting TCR signaling, has been reported. This interaction dependents on N-glycosylation mediated by the enzyme beta-1,6 N-acetylglucosaminyltransferase V (Mgat5). 71 Therefore, mice deficient in Mgat5 show a lowered T-cell activation threshold with enhanced recruitment of TCRs to agonist-coated beads, and actin microfilament re-organization. 71 In contrast to the latter, in human CD4 þ CD25 hi derived T reg cells, that express LGALS3, we have observed a dynamic impairment of actin remodeling compared to CD4 þ CD25 À T cells. 72 The addition of soluble LGALS3 to Jurkat T cells has been reported to trigger a sustained influx of extracellular Ca 2 þ that can be blocked by lactose. 73 As a sustained Ca 2 þ flux in T reg cells following TCR stimulation was observed in our case, LGALS3 released from the cells might act in an autocrine manner and modulate the Ca 2 þ homeostasis of T reg cells. However, similar to T cells of mice, 44 we did not detect significant cell surface bound LGALS3 in resting or activated T reg cells. We, therefore, excluded a paracrine effect of LGALS3 in the process of suppression of antigen-induced T h cell proliferation by T reg cells, suggesting that LGALS3 released by T reg cells might not reach amounts needed to induce either apoptosis or sustained Ca 2 þ flux. 69, 73 In general, the approach to reprogram antigenspecific effector T h cells into therapeutic regulatory T cells by the transduction of FOXP3 is very encouraging. Clearly, however, only a partial regulatory phenotype can be induced by FOXP3 overexpression in effector T h cells compared to CD4 þ CD25 hi derived T reg cells. FOXP3-transduced T h cells show less proliferative impairment and suppressor function, and less induction of LGALS3 expression. They further downregulate CD25 expression, and still secrete effector cytokines like IFNg. Based on the observation that FOXP3 protein is expressed in human effector T h cells, inevitable mechanisms must exist that control the overwhelming negative effects of FOXP3 in human effector CD4 þ T cells. Our analysis identified LGALS3 as a FOXP3-dependent signature differentiating between a regulatory and an effector program.
LGALS3 is expressed at high constitutive levels only in antigen-stimulated CD4 þ CD25 hi derived T reg cells. Moreover, we identified UBD as a downstream effector of FOXP3 involved mainly in the regulation of anergy. Thus, our analysis provides a focused starting point for further elucidation of genetic and mechanistic aspects of active immunosuppression and of differences between human and mouse regulatory T cells. This will ultimately lead to a complete understanding of human regulatory T cells.
